| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.11 | 0.6 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |